Mode
Text Size
Log in / Sign up

Oncoplastic breast-conserving surgery reduces risk of initial positive margins and margin-related reoperations in breast cancerOncoplastic surgery may reduce repeat operations for breast cancer patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider oncoplastic breast-conserving surgery to reduce the risk of initial positive margins and margin-related reoperations.

This meta-analysis evaluated the outcomes of oncoplastic breast-conserving surgery (OBCS) compared to conventional breast-conserving surgery (BCS) in a large cohort of 124,903 observations. The analysis focused on margin-related outcomes and local recurrence in patients undergoing surgery for breast cancer.

The meta-analysis found that OBCS was associated with significantly lower risks for several primary outcomes: initial positive margins (RR 0.57, 95% CI 0.40-0.80), re-excision (RR 0.59, 95% CI 0.46-0.77), completion or conversion mastectomy (RR 0.62, 95% CI 0.43-0.90), and any margin-related reoperation (RR 0.63, 95% CI 0.51-0.78). Conversely, a higher likelihood of achieving a negative or clear margin was observed with OBCS (RR 1.07, 95% CI 1.04-1.11). No significant differences were found between the two groups regarding local recurrence.

Authors noted that complication estimates should be interpreted cautiously because reporting and ascertainment varied across study designs. The findings suggest that OBCS may offer more favorable margin-related outcomes without increasing the risk of local recurrence. These results may inform surgical planning for patients undergoing breast-conserving procedures.

How this fits prior evidence

This meta-analysis addresses a gap in surgical management for breast cancer by evaluating the efficacy of oncoplastic techniques. While prior coverage has discussed biological mechanisms of resistance, environmental factors in carcinogenesis, and the role of PCSK9 in tumor growth, this study focuses on the surgical management of margin integrity. It provides evidence that OBCS may improve margin-related outcomes compared to conventional methods.

When a patient undergoes surgery for breast cancer, the goal is to remove the tumor while preserving as much healthy tissue as possible. One major concern is the surgical margin, which is the edge of the tissue removed. If cancer cells are found at that edge, the patient may need a second surgery to ensure all cancer is gone. This can be a stressful and physically demanding experience.

A large review of over 120,000 cases compared two methods: conventional breast-conserving surgery and oncoplastic breast-conserving surgery (OBCS). The results showed that patients who had the oncoplastic approach were less likely to have a positive margin initially. They also faced a lower risk of needing a re-excision, a conversion to a mastectomy, or any other operation related to the margins.

While the study showed fewer repeat procedures for those with oncoplastic surgery, it did not find a difference in the rate of local cancer recurrence. There were some notes regarding complications; while some reports showed a higher risk of complications in the oncoplastic group, these numbers were less clear when looking at specific types of data. Because different clinics report complications differently, these specific safety numbers should be viewed with caution.

What this means for you:
Oncoplastic surgery may reduce the need for follow-up operations while keeping cancer recurrence rates steady.

Common questions

What is oncoplastic breast-conserving surgery?

Oncoplastic breast-conserving surgery (OBCS) is a technique used during breast cancer treatment. It combines cancer removal with procedures to reshape or reconstruct the breast. This study looked at how this method compares to conventional surgery in terms of surgical margins and the need for follow-up operations.

Does oncoplastic surgery reduce the need for extra operations?

Yes, the data shows that patients who had oncoplastic surgery had a lower risk of initial positive margins, re-excision, and conversion to a mastectomy. Specifically, the risk of any margin-related reoperation was lower compared to conventional surgery.

Is oncoplastic surgery safer than conventional surgery?

The study found that while some reports showed a higher risk of complications for oncoplastic surgery, these results were less clear when excluding certain types of data. Because different studies report complications differently, these safety figures should be interpreted carefully. Talk to your doctor about the best approach for your specific case.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
BackgroundOncoplastic breast-conserving surgery (OBCS) may permit wider excision within a breast-conserving approach, but its effects on margin control and subsequent surgery remain uncertain.MethodsWe searched PubMed/MEDLINE, Embase, Web of Science Core Collection, Scopus, and the Cochrane Library from inception through 25 June 2026 for comparative studies of OBCS versus conventional breast-conserving surgery (BCS). Primary outcomes were initial positive margin, re-excision, completion/conversion mastectomy, and any margin-related reoperation. Secondary outcomes were negative/clear margin, recurrence, and complications. Risk ratios (RRs) with 95% confidence intervals (CIs) were pooled using random-effects Mantel–Haenszel models. Methodological quality was assessed using the Newcastle–Ottawa Scale. The protocol was registered in PROSPERO (CRD420261439265).ResultsForty-eight comparative studies comprising 124,903 BCS observations were included (28,085 OBCS; 96,818 conventional BCS). Compared with conventional BCS, OBCS was associated with lower risks of initial positive margin (RR 0.57, 95% CI 0.40–0.80), re-excision (RR 0.59, 95% CI 0.46–0.77), completion/conversion mastectomy (RR 0.62, 95% CI 0.43–0.90), and any margin-related reoperation (RR 0.63, 95% CI 0.51–0.78). OBCS was also associated with a higher likelihood of achieving negative/clear margins (RR 1.07, 95% CI 1.04–1.11). No significant between-group differences were observed in local recurrence/ipsilateral breast tumor recurrence or locoregional recurrence. Overall complication risk was higher in the primary analysis, but the association was attenuated to borderline statistical significance after exclusion of registry or administrative-database cohorts.ConclusionsOBCS was associated with more favorable margin-related outcomes and fewer margin-driven reoperations, without a detectable increase in recurrence. These findings support selective use of OBCS as a margin-control and breast-preservation strategy in appropriately selected patients. However, complication estimates should be interpreted cautiously because reporting and ascertainment varied across study designs.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD420261439265, identifier CRD420261439265.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.